About Amara Therapeutics

Amara Therapeutics is a digital therapeutics company determined to change the way pelvic healthcare is delivered globally. Our goal is to empower patients to take control of their pelvic health using evidence-based medicine and behavioral interventions supported by our Digital Therapeutic Platform.

Our mission is to provide accessible affordable effective care by connecting healthcare providers, payers, patients and peers.

By disrupting the care paradigm we can facilitate:
  • Immediate Access to Care
  • Personalized Therapies
  • Clinically Validated interventions
  • A Holistic Spectrum of Care
  • Increased Adherence
  • Cost Effectiveness
  • Effective use of patient data
Our Quality Policy
Amara Therapeutics is committed to the development of safe and effective digital therapeutics. As a company we place patient safety and product quality at the heart of everything we do. Amara Therapeutics is committed to maintaining a Quality Management System (QMS) ensuring our processes are compliant with FDA 21 CFR Part 820, ISO 13485, and other applicable standards.
Amara Therapeutics

Meet the team

Brendan Staunton
Chief Executive Officer

Brendan Staunton is the co-founder and CEO of Amara Therapeutics. Brendan has over a decade of medical device commercialisation experience working with several international medical device companies at senior management level. Brendan studied Neuroscience at University College Dublin (UCD) and holds a Master’s degree in Medical Device Innovation from NUIG and an MBA from Smurfit Business School Dublin.

Brendan is passionate about developing new medical device innovations that can have global impact. He identified to need to provide more effective early-stage treatments for pelvic and bladder health conditions during the Standford-affiliated Bioinnovate fellowship at the National University of Ireland, Galway back in in 2018. Since then, Brendan has worked tirelessly to develop solutions to these problems and is excited from the impact Amara Therapeutics can have in this field in the coming years.
Dr. Emma Carr
Chief Operating Officer
M.Ps.S.I, BA, H.Dip, MSc, PhD.

Emma Carr is the co-founder and Chief Operating Officer of Amara Therapeutics. Emma is a chartered health psychologist, experienced in developing and executing digital health interventions and clinical trials. Emma has led several digital health implementation projects for both industry and national research institutions in Ireland. Emma has lectured on multiple university programs including the MSc in Digital Health Transformation at University of Limerick and the MSc in Health Psychology at the University of Galway. She has been an invited speaker on the role of psychology in digital health for organisations such as EIT Health and Science Foundation Ireland.

Emma is passionate about creating patient centred, meaningful interventions that have the potential to transform healthcare. Her PhD research, for which she was awarded the Psychological Society of Ireland, DHP Ruth Curtis Excellence in Research Award, focused on the science of person-based intervention development in digital health. Emma ensures that the patient’s voice is always at the centre of our work at Amara Therapeutics and that the evidence we generate for our products is of the highest quality.

Dr. Geoffrey Cundiff
Chief Medical Officer

Dr. Geoffrey Cundiff is a co-founder and CMO of Amara Therapeutics. He is also a Professor in the Department of Obstetrics and Gynaecology at the University of British Columbia, where he is a research scientist at the Centre for Health Evaluation and Outcomes Sciences and the Women’s Health Research Institute. He has active trials in urogynaecology, reconstructive surgery, and obstetrics, and has research interests bridging epidemiology of pelvic floor disorders and patient centered outcomes. Dr. Cundiff is a longstanding contributor to the medical literature with more than 10,000 citations. He has published 6 books, and more than 200 peer reviewed publications, and has led several multi-centered randomized trials. He has also advocated for women suffering from pelvic floor disorders through providing leadership of professional organizations, including serving as the President of the American Urogynecologic Society.

Geoff has been a pioneer in patient centred health care and research to support it. This includes advocating for patient-reported outcomes measures, which he has both developed and validated. This focus on the patient comes from his practice in urogynaecology. He has practiced in both the United States and Canada, most recently with a clinical practice dedicated to the diagnosis and treatment of pelvic floor disorders, at the Centre for Pelvic Floor, in Vancouver British Columbia.
Katie Dunne
Quality Assurance
M.Ps.S.I, BA, MSc.

Katie Dunne is our Quality Assurance Lead at Amara Therapeutics. Katie has over nine years of experience working within large multi-national medical device companies, primarily as a Quality Engineer supporting manufacturing, problem-solving and continuous improvement activity, validations and large scale projects.

Katie has an academic background in Psychology, with a Bachelor’s degree from University College Dublin (UCD) and a Master’s degree in Psychological Science from the University of Limerick (UL). She is a graduate member of the Psychological Society of Ireland. Katie has a strong interest in improving patients' lives through innovative healthcare technologies and approaches.
Dr. Ultan Sharkey
Technical Advisor

Ultan has vast academic and practical experience in business informatics and information systems. His Masters dissertation mapped success factors of traditional information systems to ecommerce platform performance. His Doctoral research developed a novel measurement instrument based on positive psychology theories to measure behavioural intentions within ecommerce software. Ultan's work has been published in the International Journal of Ebusiness Research and he has presented research at numerous conferences. He has lectured in ecommerce strategy, decision systems, business analytics, application programming and lean methodologies. He is also an adjunct lecturer at the JE Cairnes School of Business and Economics, National University of Galway Ireland.

Ultan has held commercial roles in consulting, e-learning, and mobile applications along with technical positions in e-learning development, web development, and mobile device support. Through these roles he has developed years of experience with the commercial and technical aspects of software project management.

Scientific Advisory Board

Amara Therapeutics is supported by a wide array of Advisors, that bring knowledge and experience from clinical insights, to research skills.
Gerry Agnew, MD (Ireland)
Gerry Agnew, MD (Ireland)Consultant Urogynecologist, MSc FRCOG MRCPI
National Maternity Hospital and St. Vincent's Hospital Healthcare Group, Dublin, Ireland
Kathryn Burgio, PhD (USA)
Kathryn Burgio, PhD (USA)Professor Emeritus,
University of Alabama
Elisabeta Costantini (Italy)
Elisabeta Costantini (Italy)Professor of Urology and Urogynecology, University of Perugia
Mickey M. Karram, MD (USA)
Mickey M. Karram, MD (USA)Professor and Fellowship Program Director for Female Pelvic Medicine and Reconstructive Surgery at The Christ Hospital, University of Cinncinnati
Alayne Markland (USA)
Alayne Markland (USA)Professor of Gerintology in the Department of Medicine, University of Alabama.​
Julia Geynisman-Tan, MD, FACOG, FACS (USA)
Julia Geynisman-Tan, MD, FACOG, FACS (USA)Urogynecologist, Assistant Professor, ​Obstetrics & Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery Northwestern University
Alison C. Weidner, MD (USA)
Alison C. Weidner, MD (USA)Urogynecologist, Professor of Obstetrics and Gynecology​, Duke University Medical Center
Halina Zyczynski (USA)
Halina Zyczynski (USA) MD, FACOG. Urogynecologist, Professor of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh
Kimberly Kenton, MD, MS, FACOG, FACS (USA)
Kimberly Kenton, MD, MS, FACOG, FACS (USA)Urogynecologist, Professor of Obstetrics and Gynecology, Chief of Urogyncology and Reconstructive Pelvic Surgery, University of Chicago Medicine